R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

trend wave with Caroline Redecker and Jason Casarella pictured

Clinical trial trends and the rise of site networks

We've recently passed the midpoint of 2024, so it's a good time to check in on trends – in this case, trends in the clinical trial space.

R&D

SK Life Science Leverages Smart, Efficient Solutions Across ...

When SK Life Science began, it tapped into healthcare providers, patients, and scientists t

R&D

A spectrum of obesity requires precision

Obesity is a hot topic, and a focal research area, in the twentieth century.

R&D

Opportunity costs of gene therapies. Where do we go from her...

Over 30 gene therapies have received regulatory approval.

Patients

Houses of Parliament - a Labour government

Labour, the NHS, and life sciences: Partnerships and people

The United Kingdom this morning woke to landslide poll results: Labour is in on just 34% of the vote following the worst Conservative defeat in the party’s history.

R&D

Innovation in generics: Increased efficiency through peptide...

With the healthcare landscape continually evolving, the generic medicines industry guarantees widespread access to affordable medications for millions of patients worldwide.